Chelsea Therapeutics
Get Full AccessDescription
- Chelsea Therapeutics was a biopharmaceutical company specializing in the development of innovative products that addressed important unmet medical needs or offered alternatives to existing treatments. Chelsea's novel medication, Northera (droxidopa) for symptomatic neurogenic orthostatic hypotension was approved by the FDA in February 2014. The company was acquired by Lundbeck in June 2014.
-
Headquarters:3530 Toringdon Way Suite 200, Charlotte, North Carolina, United States
More -
Phone Number: +1 704-341-1516
-
Website: https://www.chelsearx.com
-
Employees:4
-
Revenue:$1 - 10M
-
Legal Name:Chelsea Therapeutics
-
Chelsea Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 325414 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Chelsea Therapeutics
-
Where are Chelsea Therapeutics's Headquarters?
Chelsea Therapeutics's Headquarters are in 3530 Toringdon Way Suite 200,Charlotte,North Carolina,United States
-
What is Chelsea Therapeutics's phone number?
Chelsea Therapeutics's phone number is +1 704-341-1516
-
What is Chelsea Therapeutics's official website?
Chelsea Therapeutics's official website is https://www.chelsearx.com
-
What is Chelsea Therapeutics's Revenue?
Chelsea Therapeutics's revenue is $1 - 10M
-
What is Chelsea Therapeutics's NAICS code?
Chelsea Therapeutics's NAICS code is 325414
-
How many employees are working in Chelsea Therapeutics
Chelsea Therapeutics has 4 employees
-
What is Chelsea Therapeutics's Industry?
Chelsea Therapeutics is in the industry of Pharmaceuticals
-
Who is Chelsea Therapeutics's Vice President Operations?
Chelsea Therapeutics's Vice President Operations is Joe Oliveto